Esophageal candidiasis secondary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]
Overview
Overview
Secondary prevention strategies following esophageal candidiasis in HIV patients include prophylactic fluconazole therapy.
Secondary prevention
Secondary prevention
- Secondary prevention strategies following esophageal candidiasis in HIV patients include prophylactic fluconazole therapy in a dose of 100-200 mg repeated 3 times/week.[1]
- It has been proven to decrease recurrence of esophageal candidiasis.
References
References
- ↑ Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD (2016). “Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America”. Clin. Infect. Dis. 62 (4): e1–50. doi:10.1093/cid/civ933. PMC 4725385. PMID 26679628.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH